- The Hospital Antifungal Market Guide (U.S. & Europe)
The Hospital Antifungal Market Guide (U.S. & Europe)
A syndicated clinical audit of hospital systemic antifungal drug usage covering acute care hospitals in the United States, Italy, Germany, France, U.K. and Spain. The information in the audit is abstracted directly from hospital source documents from a panel of demographically representative acute care hospitals of all sizes, including transplant centers. Users of this audit have the capability to monitor inpatient shares, costs, and the clinical use of systemic antifungal agents. For every therapeutic drug course there is a link between drug, diagnosis and suspected or confirmed fungal pathogen. The U.S. audit is published twice a year in March and September and the European data is published once each year in April.
Download brochure